Zenitar
Chengdu
About Zenitar
Zenitar is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $155.7M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2026)
- Website: zenitar.com.cn
- Phone: +86 028-83165612
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/zenitar-40835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.